OBJECTIVE: The aim of the study was to report the type and tolerance of the interface chosen for long-term noninvasive positive pressure ventilation (NPPV) in children. METHODS: This was a descriptive study carried out in the clinical setting of a pediatric university hospital in which all children started on long-term NPPV over a 18-month period were included. RESULTS: NPPV was started in 97 children with neuromuscular disease or thoracic scoliosis (n = 35), obstructive sleep apnea with (n = 32) or without (n = 21) maxillofacial deformity, or lung disease (n = 9). All 25 children ≤ 2 years of age, as well as four older children, were fitted with custom-made nasal masks; all other children were fitted with an industrial nasal mask (50%), a facial mask (16%), or nasal prongs (2%). Industrial masks with and without manufactured leaks were used in 33 (34%) and 35 (36%) children, respectively. All patients with obstructive sleep apnea used interfaces with manufactured leaks, whereas all patients with neuromuscular disease or thoracic scoliosis used interfaces without manufactured leaks. Both types of interfaces were used in patients with lung disease. The interface had to be changed in 20 patients because of discomfort (n = 16), leaks (n = 4), facial growth (n = 3), skin injury (n = 2), or change of the ventilatory mode (n = 2). A second or third mask change was necessary in nine and four patients, respectively. CONCLUSION: The choice of the interface for NPPV in children is determined by the patient's age and the underlying disease. Discomfort is the main reason for mask change.
OBJECTIVE: The aim of the study was to report the type and tolerance of the interface chosen for long-term noninvasive positive pressure ventilation (NPPV) in children. METHODS: This was a descriptive study carried out in the clinical setting of a pediatric university hospital in which all children started on long-term NPPV over a 18-month period were included. RESULTS: NPPV was started in 97 children with neuromuscular disease or thoracic scoliosis (n = 35), obstructive sleep apnea with (n = 32) or without (n = 21) maxillofacial deformity, or lung disease (n = 9). All 25 children ≤ 2 years of age, as well as four older children, were fitted with custom-made nasal masks; all other children were fitted with an industrial nasal mask (50%), a facial mask (16%), or nasal prongs (2%). Industrial masks with and without manufactured leaks were used in 33 (34%) and 35 (36%) children, respectively. All patients with obstructive sleep apnea used interfaces with manufactured leaks, whereas all patients with neuromuscular disease or thoracic scoliosis used interfaces without manufactured leaks. Both types of interfaces were used in patients with lung disease. The interface had to be changed in 20 patients because of discomfort (n = 16), leaks (n = 4), facial growth (n = 3), skin injury (n = 2), or change of the ventilatory mode (n = 2). A second or third mask change was necessary in nine and four patients, respectively. CONCLUSION: The choice of the interface for NPPV in children is determined by the patient's age and the underlying disease. Discomfort is the main reason for mask change.
Authors: Maria Pia Villa; Jacopo Pagani; Rosa Ambrosio; Roberto Ronchetti; Edoardo Bernkopf Journal: Am J Respir Crit Care Med Date: 2002-10-15 Impact factor: 21.405
Authors: R J Ruben; L Newton; D Jornsay; R Stein; H Chambers; J Liquori; C Lawrence Journal: Ann Otol Rhinol Laryngol Date: 1982 Nov-Dec Impact factor: 1.547
Authors: Ha Trang; Jean-François Brunet; Hermann Rohrer; Jorge Gallego; Jeanne Amiel; Tiziana Bachetti; Kenneth H Fischbeck; Thomas Similowski; Christian Straus; Isabella Ceccherini; Debra E Weese-Mayer; Matthias Frerick; Katarzyna Bieganowska; Linda Middleton; Francesco Morandi; Giancarlo Ottonello Journal: Orphanet J Rare Dis Date: 2014-12-05 Impact factor: 4.123
Authors: Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J R Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2013-01-22 Impact factor: 17.440
Authors: Maria L Castro-Codesal; Kristie Dehaan; Prabhjot K Bedi; Glenda N Bendiak; Leah Schmalz; Sherri L Katz; Joanna E MacLean Journal: PLoS One Date: 2018-01-30 Impact factor: 3.240
Authors: Prabhjot K Bedi; Maria Luisa Castro-Codesal; Robin Featherstone; Mohammed M AlBalawi; Bashar Alkhaledi; Anita L Kozyrskyj; Carlos Flores-Mir; Joanna E MacLean Journal: Front Pediatr Date: 2018-02-12 Impact factor: 3.418